ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $216,000 | -79.4% | 15,354 | -65.9% | 0.02% | -83.2% |
| Q4 2021 | $1,050,000 | -8.8% | 44,980 | -4.7% | 0.11% | -4.5% |
| Q2 2021 | $1,151,000 | +93.4% | 47,189 | +284.1% | 0.11% | +62.3% |
| Q2 2020 | $595,000 | -32.5% | 12,285 | -40.4% | 0.07% | -19.8% |
| Q4 2019 | $881,000 | -46.9% | 20,601 | -55.3% | 0.09% | -33.3% |
| Q3 2019 | $1,660,000 | +230.0% | 46,114 | +146.2% | 0.13% | +360.7% |
| Q1 2019 | $503,000 | +35.2% | 18,727 | -18.5% | 0.03% | +40.0% |
| Q4 2018 | $372,000 | – | 22,975 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |